Literature DB >> 6804312

Pancreatic exocrine function in severe human chronic renal failure.

C Owyang, L J Miller, E P DiMagno, J C Mitchell, V L Go.   

Abstract

Patients with chronic renal failure have an abnormal immunoreactive gastrointestinal hormone profile, which is characterised by raised fasting serum concentrations of hormones that have antagonistic effects on exocrine pancreatic function. In addition, in this present study we have found that in renal insufficiency cholecystokinin disappears slowly from the plasma after a constant intravenous infusion of the hormone (p = 0.05 compared with healthy subjects). To evaluate whether the stimulatory or inhibitory hormones have a predominant effect, pancreatic exocrine function under conditions of mannitol perfusion of the duodenum and continuous intravenous cholecystokinin stimulation was studied in eight patients who had severe chronic renal failure and eight age-matched and sex-matched control subjects. Compared with healthy subjects, patients with renal insufficiency had hypersecretion of trypsin in response both to mannitol perfusion of the duodenum and to cholecystokinin stimulation (p less than 0.05). No significant differences in lipase secretion were noted between the patients with renal insufficiency and control subjects. These findings are consistent with the hypothesis that, of the abnormally raised fasting serum concentrations of gastrointestinal hormones found in renal insufficiency, hormones that stimulate rather than inhibit pancreatic exocrine function predominate. Secondly, the dissociation between trypsin and lipase outputs in chronic renal failure may suggest a differential trophic influence of stimulatory hormones -- that is, hypercholecystokininaemia -- on pancreatic exocrine enzyme secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804312      PMCID: PMC1419670          DOI: 10.1136/gut.23.5.357

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Intraluminal and postabsorptive effects of amino acids on pancreatic enzyme secretion.

Authors:  E P DiMagno; V L Go; H J Summerskill
Journal:  J Lab Clin Med       Date:  1973-08

2.  Characteristics of inhibition of pancreatic secretion by glucagon.

Authors:  S J Konturek; J Tasler; W Obtulowicz
Journal:  Digestion       Date:  1974       Impact factor: 3.216

3.  Altered pancreatic and biliary function after vagotomy and pyloroplasty.

Authors:  J R Malagelada; V L Go; W H Summerskill
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

4.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

5.  [Exocrine pancreatic function in chronic kidney failure].

Authors:  K A Wittich; H Schmidt; F Scheler; W Creutzfeldt
Journal:  Verh Dtsch Ges Inn Med       Date:  1968

6.  The function of the exocrine pancreas in chronic renal disease.

Authors:  V Bartos; J Melichar; J Erben
Journal:  Digestion       Date:  1970       Impact factor: 3.216

7.  Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique.

Authors:  V L Go; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1970-03       Impact factor: 22.682

8.  Hormonal control of pancreatic growth.

Authors:  D L Mainz; O Black; P D Webster
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

10.  Hyperglucagonemia of renal failure.

Authors:  G L Bilbrey; G R Faloona; M G White; J P Knochel
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more
  17 in total

1.  Impaired fecal elastase excretion in uremic pancreopathy.

Authors:  M Ventrucci; A Cipolla; M Middonno; C Racchini; P Simoni; K Afandi; F Grammatico; C Campieri
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Sonographic changes of the pancreas in chronic renal failure.

Authors:  M M Lerch; J Riehl; H Mann; I Nolte; H G Sieberth; S Matern
Journal:  Gastrointest Radiol       Date:  1989

Review 3.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 1. Secretagogues used in tests of pancreatic secretion.

Authors:  E J Boyd; K G Wormsley
Journal:  Int J Pancreatol       Date:  1987-06

Review 4.  Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.

Authors:  Aslam Khan
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

5.  Pancreas in end stage renal disease.

Authors:  E P DiMagno
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

6.  Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology.

Authors:  M J Bruno; D J van Westerloo; W T van Dorp; W Dekker; J Ferwerda; G N Tytgat; N H Schut
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 7.  Acute pancreatitis in children on chronic maintenance dialysis.

Authors:  Enrico Vidal; Irene Alberici; Enrico Verrina
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

8.  Advances in managing acute pancreatitis.

Authors:  Matthew J Dimagno; Erik-Jan Wamsteker; Anthony T Debenedet
Journal:  F1000 Med Rep       Date:  2009-07-27

Review 9.  Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research.

Authors:  Sohail Z Husain; Veronique Morinville; John Pohl; Maisam Abu-El-Haija; Melena D Bellin; Steve Freedman; Peter Hegyi; Melvin B Heyman; Ryan Himes; Chee Y Ooi; Sarah J Schwarzenberg; Danielle Usatin; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-04       Impact factor: 2.839

10.  Gastric and pancreatic functions in haemodialyzed patients.

Authors:  J Malyszko; S Sosnowski; M Mazerska; M Raimer; J Romatowski; J Stasiewicz; A Kemona; M Mysliwiec
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.